• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up1.22% Nasdaq Up2.00%

    Corcept Therapeutics Incorporated (CORT)

    -NasdaqCM
    5.48 Up 0.20(3.79%) 4:00PM EDT
    |After Hours : 5.48 0.00 (0.00%) 4:28PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015
    Total Revenue 16,061   14,967   13,261   11,956  
    Cost of Revenue403  364  256  439  
    Gross Profit 15,658   14,603   13,005   11,517  
    Operating Expenses
    Research Development4,634  4,089  3,612  3,341  
    Selling General and Administrative10,432  8,863  9,291  9,342  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 592   1,651   102   (1,166)
    Income from Continuing Operations
    Total Other Income/Expenses Net -   -   -   -  
    Earnings Before Interest And Taxes592  1,651  102  (1,166)
    Interest Expense611  692  703  770  
    Income Before Tax(19)959  (601)(1,936)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(19)959  (601)(1,936)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (19) 959   (601) (1,936)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (19) 959   (601) (1,936)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.